Evidence map›Paper›PMID 27658439›Full record

ArticleHaematologica2017

Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia.

Chloé Latour, Myriam F Wlodarczyk, Grace Jung, Aurélie Gineste, Nicolas Blanchard, Tomas Ganz, Marie-Paule Roth, Hélène Coppin, Léon Kautz

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Expression of the FAM132B Gene in Iranian Patients with Beta-Thalassemia.International journal of hematology-oncology and stem cell research · 2025
    Article
  5. Article
  6. Anemia of Inflammation.Advances in experimental medicine and biology · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Using the Zebrafish as a Genetic Model to Study Erythropoiesis.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Chloé LatourIRSD, Université de Toulouse, INSERM U1220, INRA U1416, ENVT, UPS, Toulouse, France.
Myriam F WlodarczykCPTP, Université de Toulouse, CNRS U5282, Inserm U1043, UPS, Toulouse, France.
Grace JungDepartment of Pathology, David Geffen School of Medicine, University of California, Los Angeles, USA.
Aurélie GinesteIRSD, Université de Toulouse, INSERM U1220, INRA U1416, ENVT, UPS, Toulouse, France.
Nicolas BlanchardCPTP, Université de Toulouse, CNRS U5282, Inserm U1043, UPS, Toulouse, France.
Tomas GanzDepartment of Pathology, David Geffen School of Medicine, University of California, Los Angeles, USA.
Marie-Paule RothIRSD, Université de Toulouse, INSERM U1220, INRA U1416, ENVT, UPS, Toulouse, France.
Hélène CoppinIRSD, Université de Toulouse, INSERM U1220, INRA U1416, ENVT, UPS, Toulouse, France leon.kautz@inserm.fr helene.coppin@inserm.fr.
Léon KautzIRSD, Université de Toulouse, INSERM U1220, INRA U1416, ENVT, UPS, Toulouse, France leon.kautz@inserm.fr helene.coppin@inserm.fr.
Inserm · FRInstitut National de Recherche en Santé Publique · MLUniversity of California, Los Angeles · USDigestive Health Research Institute · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

The role of erythroferrone in iron homeostasis and in iron-loading anemiasR01DK065029 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GANZ, TOMAS · 2004 to 2017
$4.9M
NIDDK NIH HHS R01 DK065029
6 · The paper itself

Abstract

Malaria, a major global health challenge worldwide, is accompanied by a severe anemia secondary to hemolysis and increased erythrophagocytosis. Iron is an essential functional component of erythrocyte hemoglobin and its availability is controlled by the liver-derived hormone hepcidin. We examined the regulation of hepcidin during malarial infection in mice using the rodent parasite Plasmodium berghei K173. Mice infected with Plasmodium berghei K173 develop a severe anemia and die after 18 to 22 days without cerebral malaria. During the early phase of blood-stage infection (days 1 to 5), a strong inflammatory signature was associated with an increased production of hepcidin. Between days 7 and 18, while infection progressed, red blood cell count, hemoglobin and hematocrit dramatically decreased. In the late phase of malarial infection, hepcidin production was reduced concomitantly to an increase in the messenger RNA expression of the hepcidin suppressor erythroferrone in the bone marrow and the spleen. Compared with wild-type mice, Erfe

Indexed as

AnemiaAnimalsBiomarkersCytokinesDisease Models, AnimalDisease ProgressionErythropoiesisGene Expression RegulationHepcidinsMalariaMaleMiceMice, KnockoutMuscle ProteinsParasitemiaPlasmodium bergheiBiomarkersCytokinesErfe protein, mouseHepcidinsMuscle ProteinsRNA, Messenger

Identifiers

PMID27658439
PMCPMC5210233
OpenAlexW2522399701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.